Expert Consensus Guidelines™Available GuidelinesOptimizing Pharmacologic Treatment of Psychotic Disorders
Kane JM, Leucht S, Carpenter D, Docherty JP. The Expert Consensus Guidelines™: Optimizing Pharmacologic Treatment of Psychotic Disorders. Journal of Clinical Psychiatry 2003;64(suppl 12):1-100
A growing number of atypical antipsychotics are available for clinicians to choose from in the treatment of psychotic disorders. However, a number of important questions concerning medication selection, dosing and dose equivalence, and the management of inadequate response, compliance problems, and relapse have not been adequately addressed by clinical trials. There is also a need for information to guide clinicians in the use of long-acting atypical antipsychotics, which are expected to be available in the near future. To aid clinical decision-making, a consensus survey of expert opinion on the pharmacologic treatment of psychotic disorders was undertaken to address questions not definitively answered by the research literature. A written survey with 60 questions and 994 options was sent to 50 national experts, 47 (94%) of whom completed it. The results of this survey were used to develop a set of user-friendly guidelines that cover 1) medication selection, dosing, and dose equivalence, 2) compliance issues, 3) use of long-acting atypical antipsychotics, and 4) how to definite remission and recovery in psychotic disorders.
Optimizing Pharmacologic Treatment of Psychotic Disorders Click here for credit card orders or send a check or money order for $19.95 to: Comprehensive NeuroScience, Inc., Attn: Paola Vega, 21 Bloomingdale Rd., White Plains, NY 10605. *The CME program for this product has expired.
EXPERT CONSENSUS GUIDELINES is a trademark of Expert Knowledge Systems, LLC. Copyright (1996-2007), Expert Knowledge Systems, LLC. All rights reserved. Page last modified 1/20/06
|